Anaergia (ANRG) Q2 2024 earnings summary

Executive summary

• Q2 2024 marked progress in transitioning to a capital-light business model, with improved gross margins and adjusted EBITDA despite a significant revenue decline.

• Focus remains on margin improvement, expense reduction, and cash conservation, leveraging proprietary technologies for sales growth.

Financial highlights

• Revenues fell 45% year-over-year to $23.6M in Q2 2024, mainly due to completed Italian Capital Sales projects and project delays.

• Gross profit margin rose to 17.6% from 9.0% in Q2 2023, driven by a shift to higher-margin contracts.

• Net loss improved by 89% to $13.4M, reflecting the absence of prior year one-time losses and lower SG&A expenses.

• Adjusted EBITDA loss narrowed to $8.0M from $19.6M year-over-year.

• For the six months ended June 30, 2024, revenue was $48.6M (down 39%), with a gross margin of 22% (up from 11%).

Outlook and guidance

• Management continues to prioritize margin expansion, cost control, and cash preservation as the business model shifts.

• Forward-looking statements caution that actual results may differ due to risks and uncertainties.